Comparative renal risk of long-term use of beta-lactams in combination with vancomycin across the continuum of care

BACKGROUND: Data are controversial regarding nephrotoxicity risk with vancomycin plus piperacillin–tazobactam (VPT) compared to vancomycin alone or in combination with other beta-lactams (BLs) in acute care use. Furthermore, data are lacking on the incidence of acute kidney injury (AKI) with long-te...

Descripción completa

Detalles Bibliográficos
Autores principales: Dolly, Lauren M., Rivera, Christina G., Jensen, Kelsey L., Mara, Kristin C., Schreier, Diana J., Virk, Abinash, Arensman Hannan, Kellie N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Outpatient Parenteral Antimicrobial Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422906/
https://www.ncbi.nlm.nih.gov/pubmed/37576023
http://dx.doi.org/10.1177/20499361231189589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422906/
https://www.ncbi.nlm.nih.gov/pubmed/37576023
http://dx.doi.org/10.1177/20499361231189589

Ejemplares similares